Premium
LakeShore Biopharma Company Ltd (LSB)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Fin d'année 31 Mars 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Return on Assets (%) | -35.716 | -18.143 | -17.933 | -26.817 |
| Return on Equity (%) | 81.923 | 39.189 | -1922.88 | -65.994 |
| Return on Invested Capital (%) | -40.424 | -14.886 | -14.109 | -31.947 |
| Operating Margin (%) | -56.293 | -19.555 | -16.515 | -71.649 |
| Net Profit Margin (%) | -81.099 | -47.056 | -41.25 | -75.593 |
| Book Value Per Share | 2.801 | 2.388 | 6.989 | 2.702 |
| Earnings Per Share | -0.843 | -0.957 | -3.046 | -2.279 |
| Cash Per Share | 1.579 | 1.096 | 3.977 | 1.295 |
| Working Capital Per Share | 1.57 | 1.168 | 4.054 | 0.531 |
| Operating Profit Per Share | 0.911 | 1.686 | 6.131 | 2.617 |
| EBIT Per Share | -0.705 | -0.409 | -1.551 | -2.393 |
| EBITDA Per Share | -0.705 | -0.409 | -1.551 | -2.393 |
| Free Cash Flow Per Share | -0.532 | 0.126 | -2.827 | -2.268 |
| Fin d'année 31 Mars 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
| Actions en circulation | 247,31M | 247,31M | 93,06M | 190,23M |
| Fin d'année 31 Mars 2024 | Juin 2023 | Sept 2023 | ||
|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Actions en circulation | 93,06M | 93,06M | ||
| Return on Assets (%) | N/A | N/A | ||
| Return on Equity (%) | N/A | N/A | ||
| Return on Invested Capital (%) | N/A | N/A | ||
| Operating Margin (%) | -35.229 | N/A | ||
| Net Profit Margin (%) | -39.451 | N/A | ||
| Sales Per Share | N/A | N/A | ||
| Book Value Per Share | N/A | N/A | ||
| Earnings Per Share | N/A | N/A | ||
| Cash Per Share | N/A | N/A | ||
| Working Capital Per Share | N/A | N/A | ||
| Operating Profit Per Share | N/A | N/A | ||
| EBIT Per Share | N/A | N/A | ||
| EBITDA Per Share | N/A | N/A | ||
| Free Cash Flow Per Share | N/A | N/A | ||
| Current Ratio | N/A | N/A | ||
| Quick Ratio | N/A | N/A | ||
| Inventory Turnover (Days) | N/A | N/A |
| Capitalisation boursière | 45,79M |
| Ratio cours/bénéfice | -0,11 |
| Ratio prix/ventes | 0,08 |
| Ratio prix/liquidités | 0,19 |
| Ratio prix/valeur comptable | 0,08 |
| Rendement de dividende | - |
| Actions en circulation | 19,08M |
| Volume moyen (1 semaine) | 8,66k |
| Volume moyen (1 mois) | 8,86k |
| Variation sur 52 semaines | -77,98% |
| Plus haut sur 52 semaines | 11,20 |
| Plus bas sur 52 semaines | 1,88 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
